Bodycote (BOY) Competitors

Spirax-Sarco Engineering has a net margin of 11.36% compared to Bodycote's net margin of 7.87%. Spirax-Sarco Engineering's return on equity of 16.03% beat Bodycote's return on equity.

Spirax-Sarco Engineering pays an annual dividend of GBX 170 per share and has a dividend yield of 2.4%. Bodycote pays an annual dividend of GBX 23 per share and has a dividend yield of 2.5%. Spirax-Sarco Engineering pays out 63.3% of its earnings in the form of a dividend. Bodycote pays out 68.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Spirax-Sarco Engineering has a beta of 1.144, meaning that its stock price is 14% more volatile than the broader market. Comparatively, Bodycote has a beta of 1.352, meaning that its stock price is 35% more volatile than the broader market.

In the previous week, Spirax-Sarco Engineering and Spirax-Sarco Engineering both had 5 articles in the media. Spirax-Sarco Engineering's average media sentiment score of 0.37 beat Bodycote's score of -0.06 indicating that Spirax-Sarco Engineering is being referred to more favorably in the media.

Spirax-Sarco Engineering has higher revenue and earnings than Bodycote. Spirax-Sarco Engineering is trading at a lower price-to-earnings ratio than Bodycote, indicating that it is currently the more affordable of the two stocks.

Spirax-Sarco Engineering presently has a consensus target price of GBX 8,155, indicating a potential upside of 14.22%. Bodycote has a consensus target price of GBX 881.33, indicating a potential downside of 3.15%. Given Spirax-Sarco Engineering's higher probable upside, equities analysts plainly believe Spirax-Sarco Engineering is more favorable than Bodycote.

71.7% of Spirax-Sarco Engineering shares are held by institutional investors. Comparatively, 64.6% of Bodycote shares are held by institutional investors. 0.5% of Spirax-Sarco Engineering shares are held by company insiders. Comparatively, 1.3% of Bodycote shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Bodycote pays an annual dividend of GBX 23 per share and has a dividend yield of 2.5%. Rotork pays an annual dividend of GBX 8.30 per share and has a dividend yield of 1.7%. Bodycote pays out 68.5% of its earnings in the form of a dividend. Rotork pays out 56.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Rotork has higher revenue and earnings than Bodycote. Bodycote is trading at a lower price-to-earnings ratio than Rotork, indicating that it is currently the more affordable of the two stocks.

Rotork has a net margin of 15.75% compared to Bodycote's net margin of 7.87%. Rotork's return on equity of 21.48% beat Bodycote's return on equity.

Bodycote presently has a consensus target price of GBX 881.33, indicating a potential downside of 3.15%. Rotork has a consensus target price of GBX 433.50, indicating a potential downside of 11.24%. Given Bodycote's higher probable upside, analysts clearly believe Bodycote is more favorable than Rotork.

64.6% of Bodycote shares are held by institutional investors. Comparatively, 59.2% of Rotork shares are held by institutional investors. 1.3% of Bodycote shares are held by insiders. Comparatively, 5.5% of Rotork shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

In the previous week, Bodycote had 4 more articles in the media than Rotork. MarketBeat recorded 5 mentions for Bodycote and 1 mentions for Rotork. Rotork's average media sentiment score of 0.00 beat Bodycote's score of -0.06 indicating that Rotork is being referred to more favorably in the news media.

Bodycote has a beta of 1.352, meaning that its stock price is 35% more volatile than the broader market. Comparatively, Rotork has a beta of 1.053, meaning that its stock price is 5% more volatile than the broader market.

Bodycote has a beta of 1.352, indicating that its share price is 35% more volatile than the broader market. Comparatively, Goodwin has a beta of 0.659, indicating that its share price is 34% less volatile than the broader market.

Bodycote has higher revenue and earnings than Goodwin. Goodwin is trading at a lower price-to-earnings ratio than Bodycote, indicating that it is currently the more affordable of the two stocks.

In the previous week, Bodycote and Bodycote both had 5 articles in the media. Goodwin's average media sentiment score of 0.62 beat Bodycote's score of -0.06 indicating that Goodwin is being referred to more favorably in the news media.

Bodycote pays an annual dividend of GBX 23 per share and has a dividend yield of 2.5%. Goodwin pays an annual dividend of GBX 280 per share and has a dividend yield of 2.1%. Bodycote pays out 68.5% of its earnings in the form of a dividend. Goodwin pays out 37.9% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

64.6% of Bodycote shares are owned by institutional investors. Comparatively, 5.1% of Goodwin shares are owned by institutional investors. 1.3% of Bodycote shares are owned by insiders. Comparatively, 3.8% of Goodwin shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Goodwin has a net margin of 15.93% compared to Bodycote's net margin of 7.87%. Goodwin's return on equity of 34.20% beat Bodycote's return on equity.

Bodycote currently has a consensus target price of GBX 881.33, indicating a potential downside of 3.15%. Given Bodycote's stronger consensus rating and higher probable upside, equities research analysts clearly believe Bodycote is more favorable than Goodwin.

Bodycote has a net margin of 7.87% compared to ITM Power's net margin of -108.00%. Bodycote's return on equity of 9.30% beat ITM Power's return on equity.

ITM Power presently has a consensus target price of GBX 5,062.50, indicating a potential upside of 4,987.94%. Bodycote has a consensus target price of GBX 881.33, indicating a potential downside of 3.15%. Given ITM Power's higher possible upside, analysts clearly believe ITM Power is more favorable than Bodycote.

ITM Power has a beta of 2.85, indicating that its share price is 185% more volatile than the broader market. Comparatively, Bodycote has a beta of 1.352, indicating that its share price is 35% more volatile than the broader market.

In the previous week, Bodycote had 4 more articles in the media than ITM Power. MarketBeat recorded 5 mentions for Bodycote and 1 mentions for ITM Power. ITM Power's average media sentiment score of 0.75 beat Bodycote's score of -0.06 indicating that ITM Power is being referred to more favorably in the media.

7.4% of ITM Power shares are held by institutional investors. Comparatively, 64.6% of Bodycote shares are held by institutional investors. 7.9% of ITM Power shares are held by company insiders. Comparatively, 1.3% of Bodycote shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Bodycote has higher revenue and earnings than ITM Power. ITM Power is trading at a lower price-to-earnings ratio than Bodycote, indicating that it is currently the more affordable of the two stocks.